The INSPECT Act proposes to establish dedicated Inspectors General for three critical health agencies: the National Institutes of Health (NIH) , the Centers for Disease Control and Prevention (CDC) , and the Food and Drug Administration (FDA) . This measure aims to enhance oversight and accountability within these organizations. Specifically, the bill amends existing federal law to classify NIH, CDC, and FDA as "establishments" requiring their own independent Inspectors General. The President would be mandated to appoint an Inspector General for each of these agencies within one year following the bill's enactment. Importantly, the legislation stipulates that the implementation and operation of these new Inspector General offices will be funded by reallocating existing appropriations from the Department of Health and Human Services' Office of the Inspector General, ensuring no additional funds are authorized.